Analysis of Extracellular Vesicle Protein Profiles to Predict Treatment Response in a Phase II Clinical Trial with Cabozantinib and Pembrolizumab for Refractory Metastatic Pancreatic Cancer

ANNALS OF SURGICAL ONCOLOGY(2024)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要